Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model
Open Access
- 22 March 2026
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 183 (12) , 3395-3408
Abstract
Background and Purpose: Idiopathic pulmonary fibrosis is a progressive lung disease with high clinical need. In this context, nintedanib significantly reduces acute exacerbation risk, however its comprehensive effect on fibrosis remains unclear. This study aims to evaluate nintedanib transcriptomic impact on lung fibrosis to uncover molecular signatures for new therapeutics. Experimental Approach: Lung fibrosis was induced by two intratracheal bleomycin administrations. Nintedanib was administered orally daily for 3 weeks. Histological and transcriptome data were obtained using automated fibrosis quantification, Ashcroft Score and RNA sequencing, respectively. Correlation network analysis (WGCNA) modules were identified and examined by cell and pathway enrichment analysis. Lipid peroxidation was tested using malondialdehyde. Key Results: Nintedanib reduced fibrotic lesions by ~15%, decreased severe Ashcroft scores , . WGCNA identified two clusters correlated with histological parameters, where nintedanib counter‐regulates gene expression. One cluster was associated with mesenchymal cells (fibroblast and smooth muscle; −log p‐val > 4.45), energy production, cellular metabolism and extracellular matrix‐related pathways (−log q‐val > 11). The second cluster, enriched predominantly in resident macrophages (−log p‐val > 12.36), was related to lysosomal activity and lipid metabolism (−log q‐val > 21). Nintedanib inhibited bleomycin elevated malondialdehyde levels. Conclusions and Implications: The study highlighted two distinct protective effects of nintedanib on lung fibrosis. One well‐known on mesenchymal cells and matrix‐related components. Plus, one related to the involvement of the pneumocyte–macrophage paracrine lipid axis, where oxidized lipids alter macrophage activities, leading to the formation of lipid‐filled macrophages. This may open new research directions.Keywords
All Related Versions
Funding Information
- Chiesi Farmaceutici
This publication has 60 references indexed in Scilit:
- Systematic identification of cell-fate regulatory programs using a single-cell atlas of mouse developmentNature Genetics, 2022
- Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugsScientific Reports, 2022
- Nintedanib inhibits keloid fibroblast functions by blocking the phosphorylation of multiple kinases and enhancing receptor internalizationActa Pharmacologica Sinica, 2020
- Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosisRedox Biology, 2020
- The contribution of animal models to understanding the role of the immune system in human idiopathic pulmonary fibrosisClinical & Translational Immunology, 2020
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasetsNature Communications, 2019
- Lipid Uptake by Alveolar Macrophages Drives Fibrotic Responses to Silica DustScientific Reports, 2019
- Mapping the Mouse Cell Atlas by Microwell-SeqCell, 2018
- Targeting non-malignant disorders with tyrosine kinase inhibitorsNature Reviews Drug Discovery, 2010
- Phospholipid analysis of alveolar macrophages and bronchoalveolar lavage fluid following bleomycin administration to rabbitsLung, 1994